In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 39 for your search:
Country:  U.S.A.
Treatment/Intervention:  nutritional therapy
Trial Status:  Active
Sponsor of Trial:  NCI
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Active
Age: 19 and over
Sponsor: NCI, Other
Protocol IDs: 10-0366-04, NCI-2011-00710, NCT01391689

2.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: I 128308, NCI-2009-01530, P30CA016056, RPCI-I-128308, NCT00887432

3.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01434, CDR0000671302, NCI09-13-02, NWU09-13-02, N01CN35157, P30CA060553, NU-NWU09-13-02, NCT01111292

4.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 19 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000579360, UAB-F060511015, UAB-IRB0000196, F060511015, NCT00703196

5.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 to 50
Sponsor: NCI, Other
Protocol IDs: S0812, U10CA037429, NCI-2011-02032, SWOG-S0812, NCT01097278

6.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 40 and over
Sponsor: NCI, Other
Protocol IDs: MC084C, NCI-2012-00058, NCT01606124

7.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 40 to 79
Sponsor: NCI, Other
Protocol IDs: 11165, R01CA160938, NCT01661764

8.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 19 and over
Sponsor: NCI, Other
Protocol IDs: 0S-10-3, NCI-2013-00414, NCT01802346

9.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CCCWFU 98113, NCI-2013-00963, P30CA012197, NCT01869764

10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 19 and over
Sponsor: NCI, Other
Protocol IDs: R21CA161263-01A1, NCT01886677

11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 45 to 85
Sponsor: NCI, Other
Protocol IDs: CASE6812, NCI-2013-01372, P30CA043703, NCT01928485

12.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 21 and over
Sponsor: NCI
Protocol IDs: NCI-2014-00695, CO11378, UWI2013-00-01, P30CA014520, N01CN00033, N01CN35153, NCT02095145

13.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 40 to 79
Sponsor: NCI, Other
Protocol IDs: CDR0000596506, P30CA016056, RPCI-I-90206, I 90205, NCT00690924

14.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 to 59
Sponsor: NCI, Other
Protocol IDs: 06-073, R01CA127971, CDR0000629579, GCRC#724, UTMB-06073, IRB#06-073, NCT00878995

15.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000644401, UPCC-03309, IRB# 806733, NCT00955942

16.

Phase: Phase I
Type: Supportive care, Treatment
Status: Active
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: AAAD8521, NCT00976131

17.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: MCC-15630, 1R01CA129227-01A1, NCT00985777

18.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: I 163509, NCI-2010-00263, P30CA016056, NCT01093092

19.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 201102772, 1R21CA161182, NCT01419483

20.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 201102773, 1R21CA161182, NCT01419587

21.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 11043, NCI-2012-01324, 5P01CA154295-02, NCT01666756

22.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 201211713, P30CA086862, U01CA140206, NCT01752491

23.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 40 to 75
Sponsor: NCI, Other
Protocol IDs: 12-000886, NCI-2013-01153, P30CA016042, R03CA171583, NCT01912820

24.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 101681, 1R21CA166839-01A1, NCT01949519

25.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 201309759, 3P30CA086862, NCT01975766
1   
New Search